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Normal brain function requires that the overall synap-
tic activity in neural circuits be kept constant. Long-
term alterations of neural activity lead to homeostatic
regulation of synaptic strength by a process known
as synaptic scaling. The molecular mechanisms un-
derlying synaptic scaling are largely unknown.
Here, we report that all-trans retinoic acid (RA),
a well-known developmental morphogen, unexpect-
edlymediates synaptic scaling in response to activity
blockade. We show that activity blockade increases
RA synthesis in neurons and that acute RA treatment
enhances synaptic transmission. The RA-induced in-
crease in synaptic strength is occluded by activity
blockade-induced synaptic scaling. Suppression of
RA synthesis prevents synaptic scaling. This form
of RA signaling operates via a translation-dependent
but transcription-independent mechanism, causes
an upregulation of postsynaptic glutamate receptor
levels, and requires RARa receptors. Together, our
data suggest that RA functions in homeostatic plas-
ticity as a signaling molecule that increases synaptic
strength by a protein synthesis-dependent mecha-
nism.
INTRODUCTION
Normal nervous system function requires that neurons maintain
a constant overall activity level and maintain a balance between
the relative strength of individual synapses. Constant neural ac-
tivity levels are achieved by synaptic scaling, a form of homeo-
static synaptic plasticity (Davis, 2006; Turrigiano and Nelson,
2004). In synaptic scaling, all synapses of a neuron are modified
concurrently in a multiplicative fashion with greater synaptic ad-
justment to stronger synapses, thereby preserving the relative
synaptic weights of the overall circuit (Thiagarajan et al., 2005;
Turrigiano et al., 1998) (but see Echegoyen et al., 2007). Several
signaling pathways have been shown to mediate various forms
of homeostatic synaptic plasticity in the mammalian central ner-
vous system and the Drosophila neuromuscular junction. A de-308 Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc.crease in neuronal activity, for instance, has been shown to de-
crease the ratio of a/b-CaMKII protein in neurons, likely by
upregulating transcription of b-CaMKII (Thiagarajan et al.,
2002). The level of Arc/Arg3.1, an immediate-early gene that is
rapidly induced by neuronal activity associated with information
encoding in the brain (Guzowski et al., 2005), modulates homeo-
static plasticity through a direct interaction with the endocytic
pathway (Shepherd et al., 2006). At the Drosophila neuromuscu-
lar junction, homeostatic synaptic growth is regulated by TGF-b,
a synaptically released growth factor (Sweeney andDavis, 2002).
In addition to these neuron/muscle-autonomous factors, glia-
derived factors such as the cytokine TNFa were demonstrated
to control synaptic strength and to influence homeostatic synap-
tic plasticity (Beattie et al., 2002; Stellwagen andMalenka, 2006).
One particularly well-characterized form of homeostatic plas-
ticity is the increase insynaptic strength inducedbychronicblock-
ade of neuronal activity with tetrodotoxin (TTX) and the NMDA re-
ceptor antagonist APV. A series of recent studies indicate that this
form of homeostatic plasticity is mediated by the local synthesis
and synaptic insertion of homomeric GluR1 receptors, which re-
sults in an increase of synaptic glutamate receptor response as
manifested in an enhanced amplitude of unitary spontaneous
miniature EPSCs (Ju et al., 2004; Sutton et al., 2004, 2006). Al-
though several biochemical signaling pathways that trigger den-
dritic protein synthesis upon increase in neuronal activity have
been identified (Kelleher et al., 2004; Klann and Dever, 2004;
Schuman et al., 2006), signaling pathways involved in this type
of inactivity-induced synaptic scaling remain to be determined.
During development, all-trans retinoic acid (RA) regulates gene
transcription by binding to retinoic acid receptor (RAR) proteins,
which are well-characterized transcription factors of the nuclear
receptor family. In the nervous system, RA signaling is involved in
neurogenesis and neuronal differentiation. Increasing evidence
indicates that RA signaling may also play an important role in
the mature brain (Lane and Bailey, 2005). Specifically, RA is rap-
idly synthesized in various regions of the adult brain (Dev et al.,
1993). Deficiencies in retinoid metabolism and signaling cause
impaired synaptic plasticity and learning (Chiang et al., 1998;
Cocco et al., 2002; Misner et al., 2001) and may result in neuro-
logical diseases (Lane and Bailey, 2005). Consistent with the
notion that RA may have a role in the postmitotic properties of
neurons, a recent study suggested that RA induces spine forma-
tion in cultured neurons by binding to a novel, cell surface-ex-
posed variant of the RA-receptor RARa (Chen and Napoli, 2008).
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RA Mediates Homeostatic Synaptic PlasticityFigure 1. RA Induces Synaptic Scaling
(A) Representative mEPSC traces from control (DMSO) and RA-treated neurons in dissociated cultures. Scale bar: 20 pA, 20 ms.
(B) Acute RA (1 mM) treatment in cultured hippocampal slices significantly increased the amplitude but not frequency of mEPSCs in the pyramidal neurons
(DMSO, n = 11; RA, n = 16; *p < 0.0005).
(C) RA treatment increased mEPSC amplitudes in dissociated neuronal cultures (n = 11 for each group; *p < 0.01).
(D and E) RA scaled up mEPSC amplitudes multiplicatively. (D) Ranked RA amplitudes were plotted against ranked control amplitudes (green dots), and the data
arebest describedbyamultiplicative (solid line), not an additive (dashed line), increase inmEPSCamplitudes.Reddotsare control plottedagainst control andhave
a slope of 1. Best fit: RA = control 3 1.68 – 5.14, R = 0.989, p < 0.0001. (E) The cumulative distribution of mEPSC amplitudes from DMSO- (red) and RA (green)-
treated neurons (n = 11 for each group). Scaling up the DMSO distribution by a factor of 1.68 produced a good fit to the RA-treated distribution (black line).
(F) The average mEPSC frequency is not changed by RA treatment (n = 11 for each group, p > 0.9).
(G) Acute RA treatment did not induce new spine formation. GFP-transfected neurons were treated with DMSO or 1 mM RA for 1 hr and fixed. No obvious mor-
phological changes induced by RA were observed. Scale bar, 5 mm.
Error bars indicate standard errors.Here, we report that RA is a potent regulator of synaptic
strength in cultured neurons and brain slices. We demonstrate
that activity blockade—which induces homeostatic plasticity—
strongly stimulates neuronal RA synthesis. We also show that
RA rapidly increases synaptic strength and that activity-depen-
dent synaptic upscaling occludes the subsequent RA-induced
increase in synaptic strength. In addition, knocking down RARa
expression in neurons using shRNA blocked both RA-induced
and activity blockade-induced synaptic scaling. Direct activation
of RARawith a selective agonist mimics the effect of RA, indicat-
ing the essential involvement ofRARa in homeostatic plasticity. In
our experiments, the synaptic effect of RA is independent of the
formation of new dendritic spines, but instead operates by stim-
ulating the synthesis and insertion of newpostsynaptic glutamate
receptors in existing synapses. Our results thus suggest that RA
functions as a synaptic signal that operates via RARa during ho-
meostatic plasticity to upregulate synaptic strength by increasing
the size of the postsynaptic glutamate receptor response.
RESULTS
RA Mediates Scaling of Excitatory Synaptic
Transmission
We examined synaptic transmission in hippocampal pyramidal
neurons from 5–7 day in vitro (DIV) cultured slices. Two hours af-
ter the addition of RA (1 mM) to the culture media, a significant in-crease in miniature excitatory postsynaptic current (mEPSC)
amplitude was observed in comparison to DMSO-treated neu-
rons (Figures 1A and 1B). The mEPSC frequency was not
changed by RA treatment. The rapid time course of the RA effect
on synaptic transmission was somewhat surprising, raising the
question whether we could observe a similar phenomenon in dis-
sociated cultured neurons. Indeed, a significant increase in
mEPSC amplitudewas induced in primary cultured hippocampal
neurons as early as an hour after a 30 min treatment with RA
(Figure 1C). Similar to the results from cultured slices, this
RA-induced increase in synaptic transmission did not involve
an increase inmEPSC frequency (Figures 1F), suggesting a post-
synaptic mechanism. Analysis of the mEPSC amplitude distribu-
tions after DMSO or RA treatments showed that the RA-induced
increase in synaptic strength was multiplicative, rather than ad-
ditive (Figures 1D and 1E; compare green dots with dashed line
in 1D), reminiscent of synaptic scaling induced by reduced net-
work activity (Thiagarajan et al., 2005; Turrigiano et al., 1998).
A recent report suggested that RA induces rapid spine formation
by a mechanism that involves activation of the RA-receptor
RARa exposed on the cell surface (Chen and Napoli, 2008).
However, we observed no increase in spine density upon RA
treatment (Figures 1G and S1), consistent with the lack of
change in mEPSC frequency. Thus, at least under our condi-
tions, RA causes a functional change in existing synapses with-
out a major induction of new spines and synapses.Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc. 309
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RA Mediates Homeostatic Synaptic PlasticityIntrigued by the synaptic upscaling induced by RA, we next di-
rectly asked whether RA is involved in activity blockade-induced
homeostatic synaptic plasticity. To test this question, we applied
citral, an inhibitor of retinol dehydrogenase (ROLDH) (Di Renzo
et al., 2007; Song et al., 2004; Tanaka et al., 1996), the enzyme
that oxidizes all-trans retinol to all-trans retinal in the synthetic
pathway of RA (Lane and Bailey, 2005). Consistent with previous
studies (Ju et al., 2004; Sutton et al., 2004, 2006), we found that
blocking neuronal activity with TTX and APV for 24 hr induced
a significant increase in mEPSC amplitude in cultured neurons
(Figure 2A). This increase was blocked by addition of citral
(Figure 2A). Moreover, we blocked RA synthesis with 4-(diethyla-
mino)-benzaldehyde (DEAB), an inhibitor of retinal dehydroge-
nase (RALDH) (Russo et al., 1988), the enzyme that catalyzes
the next step oxidation from ROLDH and converts all-trans reti-
nal into RA. Similar to citral, DEAB completely blocked synaptic
scaling induced by activity blockade (Figure 2B). These results
suggest that RA synthesis is required for activity blockade-
induced synaptic scaling.
If activity blockade-induced synaptic scaling is mediated by
RA signaling, it should occlude further scaling effects induced
by direct RA treatment. In both hippocampal slice and primary
cultures, the homeostatic increase in synaptic strength induced
Figure 2. RA Mediates Activity Blockade-Induced Synaptic Scaling
(A) Citral, a ROLDH inhibitor, blocked TTX + APV-induced synaptic scaling.
Neurons were treated with citral (5 mM) or DMSO together with TTX + APV
for 24 hr before electrophysiological recording.While TTX +APV alone induced
synaptic scaling (n = 10 for each group, *p < 13 104), no synaptic scaling was
induced by activity blockade (n = 9 for each group, p > 0.2).
(B) DEAB (10 mM), a RALDH inhibitor, also blocked TTX + APV-induced synap-
tic scaling (n = 11 for each group, *p < 0.005; n.s., p > 0.5).
(C) Blocking neuronal activity in cultured slices with TTX and APV induced syn-
aptic scaling and occluded further increase by subsequent RA treatment
(n = 10/group, *p < 0.005).
(D) Activity blockade-induced synaptic scaling occluded further RA-induced
scaling in primary cultures (n = 10/group; *p < 0.01).
Error bars indicate standard errors.310 Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc.by blocking neuronal activity with TTX and APV for 24 hr, asman-
ifested in a significant increase in mEPSC amplitude in pyramidal
neurons, occludes the subsequent action of RA treatment (1 mM,
2 hr for slice cultures, 30 min for primary cultures) (Figures 2C
and 2D). Taken together, these data strongly suggest that RA
is critically involved in homeostatic synaptic plasticity.
Blocking Neuronal Activity Increases RA Synthesis
The intriguing possibility that activity blockade-induced synaptic
scaling is mediated by RA signaling led us to examine whether
RA synthesis can be regulated in an activity-dependent manner.
Retinoids are stored intracellularly as retinyl ester, which are
converted to retinol when needed. Retinol is then metabolized
to RA (Lane and Bailey, 2005). The oxidation that directly gener-
ates RA from retinal is catalyzed by retinal dehydrogenases
(RALDHs) (Figure 3A). High levels of RALDH1 mRNA and protein
are detected in fully differentiated hippocampal neurons, indicat-
ing that RA can be directly synthesized in neurons (Figures 3A
and S2) (Wagner et al., 2002). To examine whether activity block-
ade enhances RA levels in neurons, we employed a retinoic acid
response element (RARE)-based reporter system that has been
widely used in vivo and in vitro to detect RA (Suzuki et al., 2006;
Thompson Haskell et al., 2002; Wagner et al., 1992). We gener-
ated a reporter construct containing three copies of the DR5 var-
iant of the retinoic acid response element (direct repeat with 5 bp
of spacing) and a GFP reporter gene (3xDR5-RARE-GFP) to
monitor RA production in cultured neurons (Figure 3B). The de-
tection system was validated in HEK293 cells in which direct
RA treatment induced a robust increase in GFP when transiently
transfected with the 3xDR5-RARE-GFP reporter (Figures S3A
and S3B).
We transfected neurons at 13 DIV with 3xDR5-RARE-GFP and
examined theGFP fluorescence intensity after 6 hr. Compared to
the untreated condition, treatment with TTX and APV for 24 hr
dramatically increased the expression of the GFP reporter, while
a control GFP construct lacking the RARE regulatory sequence
showed no change in expression (Figures 3C and 3D). Interest-
ingly, blocking neuronal activity with TTX alone for 24 hr, a proto-
col that induces a mechanistically distinct form of synaptic scal-
ing (Sutton et al., 2006), did not yield a significant increase in the
GFP reporter expression (Figures 3C and 3D).
To further validate that the increased GFP reporter expression
reflects synthesis of RA in neurons, we examined the effect of the
RA synthesis blocker DEAB on reporter expression. DEAB,
added to the neurons together with TTX and APV, reduced the
GFP-reporter signal in a dose-dependent manner (Figures 3C
and 3E). At a concentration of 10 mM, which blocked synaptic
scaling induced by TTX + APV (Figure 2B), DEAB completely
blocked RA synthesis, as indicated by a lack of significant in-
crease in reporter expression (Figure 3E). It is worth noting that
even with the highest DEAB concentration (100 mM), which pre-
sumably completely blocked RA synthesis, the GFP reporter ex-
pression levels were comparable to those found in mock-treated
neurons, indicating that at basal conditions (no activity block-
ade), the ambient RA level in neurons is very low.
To rule out the possibility that the observed increase in the
GFP reporter expression was caused by activity-dependent
changes in the neuron’s general transcriptional and/or
Neuron
RA Mediates Homeostatic Synaptic Plasticitytranslational activity acting on the reporter and to directly test
whether RA can act as a diffusible signal acting on neighboring
cells (i.e., function in a cell-non-autonomous manner), we re-
peated the RA detection experiment using HEK293 cells trans-
fected with the 3xDR5-RARE-GFP reporter. An hour after trans-
fection, HEK293 cells were coplated with neurons. A significant
increase in GFP expression in the HEK293 cells was observed
as early as 8 hr after the onset of TTX and APV treatment in com-
parison to the mock-treated group, and the difference was re-
tained 24 hr after onset of the activity blockade (Figures 3F
and 3G). Treating HEK293 cells directly with TTX + APV for
24 hr did not affect 3xDR5-RARE-GFP reporter expression
(Figure S4A). In addition, a control GFP construct lacking the
RARE sequence did not show expression differences under
these conditions (Figures 3G). Although the HEK293 cells plated
directly on neurons were able to detect increased RA levels in
TTX- and APV-treated neurons, conditioned media collected
from neuronal cultures that had been treated with TTX and
APV for 24 hr did not increase 3xDR5-RARE-GFP reporter ex-
pression in HEK293 cells (Figure S4B). The lack of free RA in
Figure 3. Activity Blockade Increases RA
Production in Neurons
(A) RALDH1 expression in hippocampal neurons.
Thirteen DIV hippocampal neurons showed strong
immunoreactivity to RALDH1 (green). Neuronal
dendrites and cell bodies are labeled with MAP2
antibody (red). Scale bar, 10 mm.
(B) Schematics of the 3xDR5-RARE-GFP reporter
construct. GFP reporter is driven by a thymidine ki-
nase (TK) promoter. The transcription is regulated
by an upstream RARE sequence consisting of
three copies of DR5-RARE.
(C) Example images of 3xDR5-RARE-GFP re-
porter expression in neurons under various treat-
ments. Scale bar, 10 mm.
(D) Activity blockade by TTX and APV for 24 hr sig-
nificantly increased 3xDR5-RARE-GFP reporter
expression in neurons without changing control
GFP expression (n = 10/group; *p < 1 3 104,
single-factor ANOVA). TTX treatment for 24 hr did
not increase reporter expression (n = 9, p > 0.3).
(E) DEAB blocked the increase in 3xDR5-RARE-
GFP reporter expression by TTX + APV treatment
in a dose-dependent manner (n = 10/group; *p <
0.0005; n.s., p > 0.4).
(F and G) Prolonged neuronal activity blockade
(>8 hr) significantly increased GFP expression
levels in coplated HEK293 cells transfected with
3xDR5-RARE-GFP reporter without affecting con-
trol GFP expression (n = 15/group, *p < 0.01).
Scale bar, 10 mm. Single-factor ANOVA was
used for all statistical analysis.
Error bars represent SEM.
the conditioned media was probably
due to its lipophilic and labile nature.
Taken together, these results demon-
strate that blocking neuronal activity by
the TTX and APV treatment strongly in-
creases RA levels in neurons and that RA acts locally in these
neurons and in surrounding cells.
RA Promotes Surface Expression of GluR1-Containing
AMPA Receptors
The selective increase ofmEPSC amplitude but not frequency by
RA treatment and the lack of an effect of RA on spine density
suggest that RA acts postsynaptically to enhance synaptic
strength in existing synapses. To examine whether RA increases
synaptic transmission by increasing postsynaptic AMPA recep-
tor function, we stained the cell surface of neurons treated with
DMSO (vehicle) or 1 mM RA for surface-expressed GluR1 and
GluR2 AMPA receptor subunits (Figures 4A). Indeed, RA signifi-
cantly increased the surface levels of GluR1, but not of GluR2
(Figure 4B).
We also examined surface GluR1 expression levels with sur-
face protein biotinylation. Either RA or TTX + APV treatment
alone significantly increased the surface GluR1 level (Figures
4C and 4D). However, application of both treatments together
did not produce additional enhancement (Figures 4C and 4D),Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc. 311
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RA Mediates Homeostatic Synaptic PlasticityFigure 4. RA Increased Surface Delivery
of Homomeric GluR1 Receptors
(A) Surface staining of GluR1 andGluR2 in neurons
after 30 min of DMSO or RA treatment. The stain-
ing was performed an hour after drug washout.
Scale bar, 10 mm.
(B) RA treatment increased surface GluR1 levels
without affecting GluR2 levels (n = 10 neurons/
group; *p < 0.0005).
(C) Biotinylation of surface GluR1 in primary cul-
tured neurons after 30 min of DMSO or RA treat-
ment or after 24 hr of TTX + APV treatment.
(D) Both RA treatment and activity blockade in-
creased surface GluR1 expression, but no addi-
tional increase by RA following 24 hr TTX and
APV treatment was observed (n = 3; *p < 0.01).
(E and F) RA-induced increase in synaptic trans-
mission is completely blocked by philanthotoxin-
433 (PhTx, 5 mM) in dissociated hippocampal
cultures (n = 8; *p < 0.05). PhTx was bath applied
10 min prior to the recording. Scale bar in (E):
20 pA, 20 ms.
(G) RA-induced increase in mEPSC amplitude in
neurons from cultured slices was also sensitive
to PhTx treatment (n = 10; *p < 0.01). Single-factor
ANOVA was used for all statistical analysis.
Error bars represent SEM.consistent with our electrophysiological results demonstrating
that activity blockade-induced synaptic scaling occludes RA-
induced increase in synaptic transmission (Figures 2C and 2D).
The selective increase in GluR1 surface expression by RA sug-
gests that homomeric GluR1 receptors are inserted during RA-
induced synaptic scaling. Activity blockade-induced synaptic
scaling is mediated by homomeric GluR1 receptors and can be
blocked by philanthotoxin-433 (PhTx), a blocker of homomeric
AMPA receptors lacking theGluR2 subunit (Ju et al., 2004; Shep-
herd et al., 2006; Sutton et al., 2006; Thiagarajan et al., 2005).
Indeed, the RA-induced increase in mEPSC amplitude was
reversed by bath application of 5 mM PhTx in dissociated cul-
tures (Figures 4E and 4F) and in hippocampal slice cultures
(Figure 4G), indicating that RA-induced synaptic insertion of ho-
momeric GluR1 receptors is responsible for the observed scaling
effect. In contrast, basal synaptic transmission was not affected
by PhTx (Figure S5), which is consistent with the notion that
AMPA receptors supporting basal synaptic transmission are
GluR2-containing heteromeric receptors.
RA Induces Transcription-Independent Local
Translation of GluR1 in Dendrites
Activity blockade-induced, in particular, TTX- and APV-induced,
synaptic scaling requires dendritic protein translation (Ju et al.,
2004; Sutton et al., 2004, 2006). GluR1 mRNA is found in neuro-
nal dendrites, and is believed to be translated locally (Grooms
et al., 2006; Miyashiro et al., 1994; Poon et al., 2006). To test
whether RA induces an increase in postsynaptic GluR1, we in-312 Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc.vestigated whether RA-induced synaptic scaling depends on
gene transcription or translation. The protein synthesis inhibitor
anisomycin (40 mM) blocked the RA-induced increase in mEPSC
amplitude in both hippocampal slice cultures (Figure 5A) and dis-
sociated cultures (Figures 5B). Moreover, the increase in surface
GluR1 expression by RA treatment was also completely pre-
vented by anisomycin or cycloheximide (100 mM; see
Figure 5C). By contrast, the transcription inhibitor actinomycin
D (50 mM) failed to block the effects of RA on mEPSC amplitude
or on surface GluR1 expression (Figures 5A–5C). Thus, RA reg-
ulates synaptic transmission by a translation-dependent but
transcription-independent mechanism.
Combining in situ hybridization and immunocytochemistry, we
found that GluR1 mRNA was present in neuronal dendrites
(Figure 6A), consistent with previous reports (Grooms et al.,
2006). We next examined RA-induced local translation of
GluR1 in synaptoneurosomes isolated from 3- to 4-week-old
rat hippocampi. The synaptoneurosome preparation was en-
riched in synaptic proteins such as GluR1 and PSD-95 and
was free of nuclear proteins such as histone protein H3
(Figure 6B). Brief treatment of synaptoneurosomes with 1 or
10 mMRA for 10min at 37C specifically increased GluR1 protein
level (Figure 6C) but not other synaptic proteins such as GluR2
and PSD-95 (Figure 6D). Consistent with our results obtained
from cultured neurons and characteristic of local protein transla-
tion, the RA-induced increase in GluR1 synthesis in synapto-
neurosomes was blocked by the protein synthesis inhibitors
anisomycin and cycloheximide but was not affected by the
Neuron
RA Mediates Homeostatic Synaptic Plasticitytranscription inhibitor actinomycin D (Figure 6E). Taken together,
these results indicate that RA acts in neuronal dendrites to acti-
vate local translation of GluR1 protein in a transcription-indepen-
dent manner.
Activity Blockade- and RA-Induced Synaptic Scaling
Is RARa Dependent
Whatmolecule could be a potential mediator for this dendritic RA
signaling that we observed? Conventional retinoid signaling is
mediated by two classes of nuclear receptors, the retinoic acid
receptors (RARs) and the retinoid X receptors (RXRs), each of
which has three isotypes: a, b, and g. All-trans RA selectively ac-
tivates the RARs, but not RXRs. In hippocampal CA1-CA3 pyra-
midal cells, both the RARa transcript and RARa protein are
detected at high levels (Krezel et al., 1999; Zetterstrom et al.,
1999). Curiously, RARawas also present in synaptoneurosomes,
although its level was not changed by the RA treatment
(Figure 6D). Immunohistochemistry staining in adult hippocam-
pal slices further confirmed that RARa not only is found in the nu-
cleus but also is present in dendrites, evidenced by its colocali-
zation with a somatodendritic marker, MAP2 (Figure 6F).
To directly investigate whether RARa is required for synaptic
scaling, we used a RARa shRNA construct to acutely knock
down RARa expression in hippocampal neurons. This method
allows us to avoid confounding factors in the RARa null mice,
such as abnormal neuronal development and perinatal lethality
(LaMantia, 1999; Lufkin et al., 1993; Mark et al., 1999). The
Figure 5. RA-Induced Synaptic Scaling Is Independent of
Transcription
(A and B) RA-induced synaptic scaling was blocked by the protein synthesis
inhibitor anisomycin, but not by the transcription inhibitor actinomycin D, in
hippocampal pyramidal neurons from both slice culture (A) and dissociated
culture (B) (n = 10/group; *p < 0.005). Drug treatment was started 30 min prior
to the RA treatment and was washed out together with RA.
(C) Surface GluR1 levels in neurons were selectively increased by RA treat-
ment, whereas GluR2 levels remained unchanged. The increase in GluR1 sur-
face expression was blocked by either cycloheximide or anisomycin, but not
by actinomycin D (n = 5; *p < 0.01).
Error bars indicate standard errors.RARa shRNA efficiently reduced RARa expression in heterolo-
gous cells and neurons after 3 days of expression (Figures S6A
and S6B). Knockdown of RARa in cultured neurons did not
change basal synaptic transmission (Figures 7A–7C), surface
GluR1 or GluR2 expression (Figure 7E), or spine density
(Figure S7), suggesting that RARa does not contribute to the
maintenance of basal level of synaptic AMPA receptors or spine
morphogenesis. However, activity blockade-induced synaptic
scaling and the increase in surface GluR1 level were both com-
pletely blocked (Figures 7A, 7B, and 7E). This result was also val-
idated in hippocampal neurons from cultured slices (Figure 7D).
Surface GluR2 expression level remained unchanged under all
conditions (Figure 7E). Coexpression with a rescue RARa con-
struct resistant to shRNA (Figure S6A) completely restored the
synaptic scaling induced by activity blockade in RARa shRNA-
expressing neurons (Figure 7B). Similarly, RARa shRNA pre-
vented the increase in mEPSC amplitude induced by direct RA
treatment (Figure 7C).
Although our results indicate that RA, signaling through RARa,
regulates local GluR1 synthesis in a transcription-independent
manner, the possibility remains that the observed effects of
RARa shRNA on synaptic scaling were due to undocumented
genomic functions of RARa on the levels of GluR1 transcripts
or translation factors in dendrites. However, the total GluR1 ex-
pression level in the neurons was not altered by RARa shRNA
3 days after the transfection (Figure S8A). In addition, dendritic
GluR1 and CaMKIIa synthesis induced with a high-K+ protocol
(Gong et al., 2006; Ju et al., 2004) was as strong in RARa
shRNA-transfected neurons as in control vector (pSuper)-trans-
fected or neighboring untransfected neurons (Figures S8A and
S8B). These results rule out the possibility that RARa knockdown
alters basal GluR1 transcription or affects the general dendritic
protein translation machinery, suggesting that dendritic RARa
signaling is selectively involved in synaptic scaling.
We next directly examined the effect of RARa activation on
synaptic scaling using an RARa-selective agonist, AM580 (Liao
et al., 2004). In primary cultured neurons, treatment of 1 or
10 mM AM580 induced a significant increase in mEPSC ampli-
tude, which lasted for at least 1 hr after AM580 washout (Figures
8A and 8B). Treatment with 1 mM AM580 also significantly in-
creased the mEPSC amplitude of neurons from cultured hippo-
campal slices (Figures 8C and 8D). Similar to the action of RA
in hippocampal synaptoneurosomes, which induced rapid syn-
thesis of GluR1 protein (Figure 6C), treatment of hippocampal
synaptoneurosomeswithAM580 for 10min also induced a signif-
icant increase in the GluR1 level (Figures 8E and 8F), suggesting
that the RARa protein in dendrites indeed mediates local trans-
lation of GluR1. Taken together, these results demonstrate that
RARa is both necessary and sufficient for synaptic scaling in-
duced by activity blockade or RA treatment.
DISCUSSION
Different forms of homeostatic synaptic plasticity maintain the
stability and coding capacity of neural circuits when neuronal ac-
tivity levels are altered (Davis, 2006; Grunwald et al., 2004; Rich
and Wenner, 2007; Turrigiano and Nelson, 2004). Homeostatic
synaptic plasticity may manifest as altered presynapticNeuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc. 313
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RA Mediates Homeostatic Synaptic Plasticitytransmitter release, synaptic vesicle loading properties, postsyn-
aptic receptor functions, or neuronal membrane properties (Da-
vis, 2006; Rich and Wenner, 2007). In this study, we focused on
a specific form of homeostatic synaptic plasticity induced by ac-
tivity blockade with TTX and APV. Earlier studies indicate that,
during this form of homeostatic plasticity, blocking neuronal ac-
tivity by TTX and APV induces rapid dendritic synthesis and syn-
aptic insertion of AMPA receptors (Ju et al., 2004; Sutton et al.,
2006). Here, we show that RA acts as a synaptic signal that me-
diates the increase in postsynaptic AMPA receptor levels during
this type of activity blockade-induced homeostatic plasticity and
that RA acts by regulating dendritic protein synthesis. This form
of RA signaling requires dendritically localized RARa. This con-
clusion is based on the following evidence:
(1) Neuronal activity blockade by TTX and APV rapidly in-
creases the production of endogenous RA in cultured
neurons, suggesting that RA synthesis is regulated by
synaptic activity. A different form of synaptic scaling
Figure 6. RA Induces Local Translation of
GluR1 Proteins
(A) GluR1 mRNA was detected in neuronal den-
drites as well as in glia cells. Antisense or sense
probes against GluR1 mRNA (red) were used for
fluorescent in situ hybridization. Neuronal soma
and dendrites were labeled with MAP2 antibody
(blue). Scale bar, 10 mm.
(B) GluR1 and PSD-95 were enriched in, and his-
tone H3 was selectively absent from, the hippo-
campal synaptoneurosome fraction relative to
the whole-cell lysate.
(C) Ten minute RA treatment (0.1, 1, or 10 mM)
induced GluR1 synthesis in synaptoneurosomes
(n = 4; *p < 0.005).
(D) GluR2, PSD-95, and RARa expression were
not changed by RA treatment (n = 4, p > 0.5).
(E) RA-induced GluR1 synthesis in synaptoneuro-
somes was blocked by cycloheximide and aniso-
mycin, but not actinomycin D (n = 4; *p < 0.0005).
(F) Immunofluorescence staining of hippocampal
sections for MAP2 (green) and RARa (red; scale
bar for upper panels, 200 mm; for lower panels,
20 mm).
Error bars indicate standard errors.
that is induced by TTX treatment
alone and does not involve local
protein synthesis (Sutton et al.,
2006) did not induce RA synthesis
in neurons (Figure 3).
(2) Application of exogenous RA di-
rectly increases glutamatergic
synaptic transmission in a multipli-
cative manner that resembles syn-
aptic scaling (Figures 1A–1F).
(3) Activity blockade-induced synap-
tic scaling occludes the increase
in synaptic transmission induced
by RA (Figures 2C and 2D).
(4) Blocking RA synthesis with the retinol dehydrogenase in-
hibitor citral or the retinal dehydrogenase inhibitor DEAB
prevents expression of TTX and APV blockade-induced
homeostatic plasticity, indicating that RA is required for
this type of homeostatic plasticity (Figures 2A and 2B).
(5) The RA-induced increase in synaptic transmission in-
volves the stimulation of the synthesis and postsynaptic
insertion of GluR1-type AMPA receptors, but not of
GluR2-type AMPA receptors (Figure 4), as previously
shown for activity blockade-induced homeostatic synap-
tic plasticity (Ju et al., 2004; Shepherd et al., 2006; Sutton
et al., 2006; Thiagarajan et al., 2005).
(6) Protein synthesis inhibitors block the RA-induced in-
crease in synaptic transmission (Figures 5A and 5B),
again as previously shown for activity blockade-induced
homeostatic plasticity (Ju et al., 2004; Sutton et al.,
2006). Protein synthesis inhibitors also block the specific
synthesis and plasma membrane insertion of GluR1 re-
ceptors induced by RA (Figure 5C).314 Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc.
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aptoneurosomes, a biochemical preparation that lacks
nuclei, demonstrating that the postsynaptic effect of RA
operates by stimulating local protein synthesis (Figure 6)
(Ju et al., 2004; Sutton et al., 2006).
(8) The nuclear receptor RARa is also present in neuronal
dendrites (Figures 6D and 6F). Knocking down RARa
blocked both activity blockade-induced and RA-induced
synaptic scaling (Figure 7).
(9) Selective activation of RARa increases excitatory synap-
tic transmission and rapid synthesis of GluR1 in synapto-
neurosomes (Figure 8).
It is important to note that for most of these observations, i.e.,
wherever possible, we confirmed the findings in two systems—
cultured neurons and slices—to ensure that the findings are
not a peculiarity of dissociated cultured neurons.
The identification of RA as a signaling molecule in homeostatic
plasticity has important implications. RA may act cell-autono-
mously and as a local diffusible molecule during synaptic scal-
ing. Our observation that RARE reporter-expressing HEK cells
cocultured with neurons are able to detect increased RA synthe-
sis demonstrates that RA acts, at least in part, non-cell-autono-
mously and supports the notion that RA acts as a short-range
diffusible molecule.
Unlike input-specific synaptic plasticity (i.e., LTP and LTD), ho-
meostatic synaptic plasticity is generally believed to be triggered
by a global change in neuronal activity that involves modification
of all synapses (Thiagarajan et al., 2005; Turrigiano et al., 1998;
Turrigiano and Nelson, 2004). Recently, it has been shown, how-
ever, that local changes of activity in a segment of neuronal den-
drite can also induce homeostatic compensation in a subset of
synapses (Hou et al., 2008; Sutton et al., 2006). A diffusible signal
such as RA facilitates the expression of homeostatic synaptic
plasticity at multiple synapses of a neuron, and even of nearby
neurons. On the other hand, because the RALDH protein is pres-
ent throughout dendrites and axons, RA synthesis may be
achieved locally and regulate a subset of synapses in the event
of local homeostatic compensation. The notion that RA can be
rapidly synthesized in an activity-dependent fashion extends
Figure 7. RARa Is Required for Activity Blockade- and RA-Induced
Synaptic Scaling
(A–C) Effect of RARa knockdown on activity blockade- and RA-induced syn-
aptic scaling in primary cultured hippocampal neurons. (A) Representative
traces of mEPSCs recorded from primary cultured neurons of various experi-
mental groups. Scale bars: 20 pA, 20 ms.
(B) Inactivity-induced synaptic scaling in dissociated cultures was blocked by
RARa shRNA, and the impaired synaptic scaling was rescued by coexpression
of a shRNA-resistant mutant RARa (n = 15/group; *p < 0.05).
(C) RA-induced synaptic scaling in dissociated cultures was blocked by RARa
shRNA (n = 15/group; *p < 0.001).
(D) Activity blockade-induced synaptic scaling in cultured slices was blocked
by RARa shRNA introduced with lentivirus (n = 10/group, p < 1 3 104).
(E) Activity blockade induced a significant increase in surface GluR1 but not
GluR2 immunoreactivity, which was completely blocked by RARa knockdown
(n = 50 dendrites from 18 neurons/group; *p < 1 3 1010).
Error bars indicate standard errors.Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc. 315
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RARa Induces Synaptic Scaling and Local
GluR1 Synthesis
(A and B) Treatment of dissociated hippocampal
neurons in culture with the RARa-specific agonist
AM580 (1 mM) induced synaptic scaling in neurons
from dissociated cultures in a dose-dependent
manner (n = 10/group; *p < 0.05). Scale bars:
20 pA, 20 ms.
(C and D) Treatment of cultured hippocampal sli-
ces with 1 mM AM580 significantly increased
mEPSC amplitude of neurons (n = 16/group, p <
1 3 104). Scale bars: 20 pA, 20 ms.
(E and F) AM580 increased GluR1 synthesis in hip-
pocampal synaptoneurosomes (n = 5; *p < 0.005).
Error bars indicate standard errors.the list of signaling molecules contributing to activity-dependent
synaptic plasticity, although it remains to be determined how RA
biosynthesis is regulated by neuronal activity.
Because RA is an important regulator of pattern formation in
development and is necessary for the maintenance of epithelial
tissues in adult animals (Lotan, 1995; Morriss-Kay and Sokolova,
1996), the activity of RA is tightly controlled in tissues through
balancing the rate of RA synthesis and metabolism. A number
of key enzymes and proteins involved in RA synthesis have
been identified, including serum retinol-binding protein, cellular
retinol-binding proteins, ROLDH, RALDH, and cellular retinoic
acid-binding proteins. The final step in RA synthesis, which is
the oxidation of retinal into RA catalyzed by RALDH, is consid-
ered a rate-limiting step of RA biogenesis (Blomhoff et al.,
1991). The expression of RALDH is developmentally controlled
and further regulated by hormones and cholesterol metabolites
(Huq et al., 2006; Ruhl et al., 2006). Changes in neuronal activity
may modulate RA synthesis by altering RALDH expression in
neurons. In addition to RALDH activity, RA synthesis can be reg-
ulated by the availability of retinol, which is stored intracellularly
as retinyl ester, a reaction catalyzed by lethicine:retinol acyl-
transferase (Lane and Bailey, 2005). Sequestration of retinol as
retinyl ester limits RA synthesis, and blocking retinyl ester forma-
tion by reducing lethicine:retinol acyltransferase activity in-
creases RA levels (Isken et al., 2007). Understanding how neuro-
nal activity modulates the expression level of various enzymes in
RA synthesis will shed light on the mechanism by which neurons
homeostatically maintain their activity through regulating RA
availability.
In addition to retinoids, other molecular players, such as the
immediate-early gene Arc/Arg3.1, CaMKIIa and -b, TGF-b, and
glia cell-derived TNFa, have also been implicated in homeostatic
synaptic plasticity (Shepherd et al., 2006; Stellwagen and Mal-
enka, 2006; Sweeney and Davis, 2002; Thiagarajan et al.,
2002) (Figure 9). RA differs from these molecules, however, in
that it is the first molecule shown to regulate dendritic protein
synthesis during homeostatic plasticity. The potential interplay
between these various signaling molecules may have implica-
tions in the mechanisms involved at different stages of homeo-
static plasticity that require translational or transcriptional
events. For example, RA has been shown to regulate TNFa tran-
scription (Dheen et al., 2005; Nozaki et al., 2006), suggesting the316 Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc.exciting possibility that neuronal and glial signaling pathways in-
teract in homeostatic plasticity. In addition to homeostatic plas-
ticity, Arc/Arg3.1, CaMKIIa, and RA signaling are also involved in
LTP and/or LTD (Chiang et al., 1998; Cocco et al., 2002; Lisman
et al., 2002; Misner et al., 2001; Plath et al., 2006). These signal-
ing molecules may be components of common mechanisms for
multiple forms of synaptic plasticity, rather than specific players
for synaptic scaling. The versatility of RA signaling in regulating
transcription and translation independently in both developing
and adult brain further suggests the possibility that different
types of synaptic plasticity may interact functionally. The molec-
ular players of homeostatic plasticity are just beginning to be un-
covered. A major question arises as to how RA achieves this
astonishing effect in synaptic scaling. The results of our study
provide preliminary evidence that RARa, a known nuclear recep-
tor that regulates transcription, is also involved in translational
regulation in neuronal dendrites. It remains to be determined
how RARa achieves this regulation in dendrites. RARa protein
is found to translocate into dendritic RNA granules upon transla-
tional activation (Maghsoodi et al., 2008). Further studies will be
required the delineation of the interactions between these differ-
ent signaling pathways in homeostatic and other forms of synap-
tic plasticity.
EXPERIMENTAL PROCEDURES
DNA Constructs
To make the 3xDR5-RARE-EGFP reporter construct, three copies of the DR5
retinoic acid response elements (de The et al., 1990) were inserted end-to-
end into the AseI and BglII sites of pEGFP-N1 (Clontech, Mountain View,
CA), which also removed the pre-existing CMV promoter. A thymidine kinase
promoter from pBS-DR5-RARE (gift from Anthony LaMantia) was then in-
serted downstream of the 3xRARE into the multiple cloning site using HindIII
and PstI.
Rat RARa-GFP was amplified from rat hippocampal cDNA using the follow-
ing primers: RARa F, 50-atatctcgagatgtacgaaagtgtagaagtc-30; and RARaR, 50-
atatgaattcgtggggattgagtggctgggct-30, and inserted into XhoI/EcoRI restriction
sites of pEGFP-N1 (Clontech, Mountain View, CA).
All siRNA constructs were inserted into pSUPER-Retro GFP (Oligogene, Se-
attle, WA) according to themanufacturer’s protocol. RARa siRNAwas directed
against bases 370–388 of rat RARa (NM_031528). The sense sequence was
50-gacaagaactgcatcatca-30, and the antisense sequence was 50-tgatgatg
cagttcttgtc-30. To generate siRNA-resistant RARa, PCR-based site mutagen-
esis was used to induce a silent mutation at base 378 (C-T).
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The following mouse monoclonal primary antibodies were used in this study:
actin (Chemicon, Temecula, CA), FMRP (Chemicon), GluR2 (Chemicon),
MAP2 (Abcam), PSD95 (Affinity Bioreagents, Golden, CO), Flag (Sigma). The
following rabbit polyclonal primary antibodies were used: GFP (Abcam),
RALDH1 (Abcam), GluR1 (Oncogene-Calbiochem, San Diego, CA), GluR1
(Upstate, Charlottesville, VA), GluR2 (Chemicon), Histone, H3 CT (Upstate),
RARa (Santa Cruz Biotechnologies, Santa Cruz, CA). The following secondary
antibodies from Jackson Immuno Research (West Grove, PA) were used: anti-
mouse Cy2, anti-rabbit Cy2, anti-mouse Cy3, anti-rabbit Cy3.
Drugs and Chemicals
The following drugs and chemicals were purchased from Sigma Aldrich: all-
trans retinoic acid, philanthotoxin-433, anisomycin, actinomycin D, cyclohex-
imide, and picrotoxin. Tetrodotoxin was purchased from Tocris Biosciences
(Ellisville, MO), D-APV from Fisher. AM580 was from Biomol International, LP
(Plymouth Meeting, PA).
Cell Cultures, Transfection, Drug Treatment, and Immunolabeling
Primary hippocampal cultures were prepared from the brains of rats at embry-
onic day 22 and maintained in serum-free Neurobasal medium supplemented
with B-27 and Glutamax (GIBCO-Brl, Grand Island, NY) for 2 weeks in vitro
(Nam and Chen, 2005). Hippocampal slice cultures were prepared from 7- to
8-day-old rat pups (Schnell et al., 2002) and maintained in Neurobasal-A me-
dium supplemented with horse serum (Hyclone, Logan, UT), insulin (Sigma),
and Glutamax. Human embryonic kidney (HEK)-293 cells were cultured in Dul-
becco’s modified Eagles medium (DMEM) supplemented with 10% fetal bo-
vine serum (GIBCO-Brl). Neurons were transfected using Lipofectamine
2000 (Invitrogen, Carlsbad, CA) with a protocol described previously (Nam
and Chen, 2005). HEK293 cells were transfected using HEKfectin (BioRad,
Hercules, CA) according to the manufacturer’s instructions. Stock solutions
of all-trans RA in DMSOwere freshly made right before treatment, and the final
concentration of DMSO in culture media is 0.05% or lower. Twenty-four-hour
treatment of 1 mMTTX and 100 mMAPVwas used to induce synaptic scaling in
dissociated cultures, and 36 hr treatment of 10 mM TTX and 1 mM APV was
Figure 9. Signaling Pathways in Homeostatic Synaptic Plasticity
Induced by Neuronal Activity Blockade
Previous studies showed that a reduction in neuronal activity (top), which ulti-
mately produces an increase in synaptic strength (bottom), causes changes in
intracellular proteins Arc/Arg3.1 and CaM Kinase II (middle; [Shepherd et al.,
2006; Thiagarajan et al., 2002]) and induces TNFa secretion from glia cells
(right; [Stellwagen and Malenka, 2006]). We here propose that in addition to
these pathways that were previously shown to be required for the particular
forms of plasticity studied, activity blockade also induces an increase in RA
synthesis, which signals through RARa, directly or indirectly stimulates the in-
sertion of more GluR1-type AMPA receptors. As a result, even with reduced
neuronal activity, the increased strength of individual synapses as a conse-
quence of activation of these pathways leads to the same overall level of syn-
aptic transmission.used to induce synaptic scaling in slice cultures. Immunocytochemistry was
performed on cultures fixed with 2% paraformaldehyde (15min, room temper-
ature) and washed with PBS containing 0.3% Triton X-100 before incubation
with primary and secondary antibodies.
RA Synthesis Inhibitor Treatment
A stock solution of 5 mM citral (Sigma-Aldrich) was prepared in DMSO. Neu-
rons were treated with 5 mM citral, TTX, and APV for 24 hr prior to electrophys-
iological recording. A stock solution of 1 M 4-diethylamino-benzaldehyde
(DEAB; Sigma-Aldrich) was prepared in DMSO. Serial dilutions generated
stocks of DEAB at concentrations of 100 mM, 10 mM, 1 mM, 0.1 mM, and
0.01 mM. Neurons were treated (1:1000) with each concentration of DEAB
coincided with the onset of activity blockade and continued for 24 hr.
Lentivirus shRNA Transfer Vector and Lentivirus Production
Human U6 (Dr. John Rossi, City of Hope) was amplified from pBS-U6 using the
following primers: U6 BamHI F, 50-ataagaatgcggccgccccggggatccaagg
tcggg-30 and U6 RARa shRNA XbaI R, 50-gctctagaaaaagacaagaactgcatcat
catctcttgaatgatgatgcagttcttgtcggtgtttcgtcctttccac-30 and cloned into pBS
(Stratagene). The U6-RARa shRNA product was then subcloned into HIV U6
GFP-fill CMV-Neo (HU6G-fill CN) (a generous gift from Dr. David Schaffer,
UC Berkeley) to generate HU6RARa CN. The human synapsin (hSYN)-EGFP
cassette then replaced the CMV-Neo cassette to form HU6RARa-SG.
Lentivirus was produced as described (Tiscornia et al., 2006). Briefly, human
embryonic kidney 293T cells were transfected using the calcium phosphate
method with the transfer vector and three helper plasmids, pRSV-REV,
pIVS-vesicular stomatitis G protein (VSVg), and pMDL gag/pol at 22.5, 14.7,
8, and 5.7 mg of DNA per 15 cm plate. After 48 hr, the supernatants of eight
plates were pooled, spun at 2000 rpm for 5 min, passed through a 0.45 mm fil-
ter, and spun at 25,000 rpm through a sucrose cushion for 1.5 hr and then the
pellets were pooled and spun at 24,800 rpm for 1.5 hr before being resus-
pended in 100 ml PBS.
Electrophysiology
Whole-cell patch-clamp recordings were made at room temperature from 14–
15 DIV cultured neurons, with 4–6 MU patch pipettes filled with an internal so-
lution containing (in mM) 120 CsCl, 2 MgCl2, 5 EGTA, 10 HEPES, 0.3 Na3-GTP,
4 Na2-ATP (pH 7.35). Cultures were continuously superfused with external so-
lution (in mM, 100 NaCl, 26 NaHCO3, 2.5 KCl, 11 glucose, 2.5 CaCl2,
1.3 MgSO4, 1.0 NaH2PO4). Patch-clamp recordings from slice cultures were
also made at room temperature from 6–8 DIV slices with a 4–6 MU patch pi-
pette filled with an internal solution containing (in mM) 140 CsCl, 2 MgCl2,
5 EGTA, 10 HEPES, 0.3 Na3-GTP, 4 Na2-ATP (pH 7.35). Slices were continu-
ously superfused with external solution (in mM, 120 NaCl, 26 NaHCO3,
2.5 KCl, 11 glucose, 2.5 CaCl2, 1.3 MgSO4, 1.0 NaH2PO4). For mEPSC record-
ing, tetrodotoxin (1 mM) and picrotoxin (100 mM) were included in the external
saline. Cells were held at 60 mV. For PhTx recordings, 5 mM PhTx or vehicle
control was bath perfused for 10 min before recording. Miniature responses
were analyzed with Mini Analysis Program from Synaptosoft.
AMPA Receptor Surface Labeling Using Immunocytochemistry
Cultured hippocampal neurons (14–15 DIV) were treated with 1 mMRA or 1 mM
TTX and 100 mM APV prior to surface labeling of AMPA receptors. Cultures
were washed with PBS containing 1 mM CaCl2 and 0.5 mM MgCl2 (PBS/
Ca2+/Mg2+) with 4% sucrose. Neurons were preincubated at 37C for 10 min
with primary antibodies against GluR1 or GluR2 to allow labeling of surface
AMPA receptors and washed in ice-cold PBS/Ca2+/Mg2+. After fixation with
4% PFA + 4% sucrose, cells were blocked using a detergent-free blocking so-
lution (PBSwith 2%normal goat serum, 0.02% sodium azide) for 1 hr, followed
by secondary antibody incubation at room temp for 1 hr.
Surface Biotinylation Assay
Cultured hippocampal cells were washed four times with cold PBS/Mg2+/
Ca2+, and surface proteins were biotinylated with 1 mg/ml Ez-link sulfo-
NHS-SS-biotin (Pierce, Madison, WI) in ice-cold PBS/Ca2+/Mg2+ for 20 min
at 4C. Cells were washed with 0.1 M glycine in ice-cold PBS/Ca2+/Mg2+ to
stop further biotinylation of the surface protein. After four more washes withNeuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc. 317
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solubilized with lysis buffer (PBS with 1% Triton-X, 1% NP-40, 10% glycerol,
25 mM MgCl2, and a protease inhibitor cocktail). Lysates were centrifuged
to remove cell debris and nuclei at 14,000 rpm for 30 min. Precleared lysate
was bound overnight at 4C using Ultralink-immobilized streptavidin beads
to precipitate biotinylated proteins. Nonbiotinylated proteins were removed
by centrifugation at 1000 rpm for 3 min, and the beads were washed three
times with lysis buffer. Biotinylated surface proteins were eluted with denatur-
ing buffer at 75C. Surface-expressed AMPA receptors were detected by
western blot analysis.
siRNA Efficiency
Twenty-four hours prior to transfection, 5 3 105 HEK293 cells per well were
seeded in 6-well plates (BD). To confirm RNAi efficacy, siRNA constructs
were cotransfected with appropriate target constructs in a 3:1 ratio. Twenty-
four hours after the transfection, cells were lysed in lysis buffer (50 mM Tris
[pH 7.5], 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 10 mg/ml aprotinin,
1 mM PMSF) at a concentration of 2 3 104 cells/ml. The lysates were then
passed through a 25 1/2 G needle and run on 10% SDS polyacrylamide
gels. Proteins were transferred to Immobilon-P PVDF membranes (Millipore),
incubated in TBST (0.2%) with 5% nonfat milk for 1 hr, and immunoblotted
as per standard protocols. Detection used an HRP secondary followed by en-
hanced chemiluminescence (Pierce, Rockford, IL).
KCl-Induced Local Translation
Neurons were transfected with pSUPER or RARa siRNA for 4 days prior to KCl
treatment. Briefly, neurons plated on glass coverslips were dipped once into
a high-K+ solution (12.5 mM NaCl, 90 mM KCl, 2.6 mM MgSO4, 1 mM
NaH2PO4, 26.2 mM NaHCO3, 11 mM glucose, 10 mM glycine, 2.5 mM
CaCl2) for 1 s followed by 10 s in a 2.5 mM KCl NaHCO3-buffered solution.
This was repeated three times at room temperature before the neurons were
allowed to recover for 10 min at 37C. Following the 10 min incubation, the
neurons were immediately fixed for immunocytochemistry.
Immunocytochemistry in Slice
Hippocampal slices (400 mm thickness) were fixed in 4%paraformaldehyde for
1 hr, rinsed three times with PBS, then permeabilized with 0.5% Triton X-100
for 1 hr, and rinsed three times with PBS again. Slices were then treated with
50mMNH4Cl for 20min at room temperature, rinsed three timeswith PBS, and
blocked in 10% normal goat serum for 1 hr. Slices were subsequently incu-
bated with RARa and MAP2 antibodies for 18 hr at 4C, followed by three
1 hr washes in PBS. Cy2-conjugated goat anti-mouse and Cy3-conjugated
goat anti-rabbit secondary antibodies were then applied for 18 hr at 4C, fol-
lowed by five 1 hr PBS washes.
Image Acquisition and Quantification
For fluorescent image analysis, cells were chosen randomly from three ormore
independent batches of cultures with four or more coverslips per batch for
each construct. Fluorescent images were acquired at room temperature
with an Olympus FV1000 BX61WI laser-scanning confocal microscope, using
an Olympus Plan Apochromat 603 oil objective (N.A. 1.42, WD 0.15) or an
Olympus U-Plan Apochromat 1003 oil objective (N.A. 1.40, WD 0.12) with se-
quential acquisition setting at 10243 1024 pixel resolutions. Laser power and
photomultipliers were set such that no detectable bleedthrough occurred be-
tween different channels. Digital images of the cells were captured with
FV1000 Imaging software (Olympus). Eight to ten sections were taken from
top to bottom of the specimen, and brightest point projections were made. Im-
ages for the same experiments were taken using identical settings for laser
power, photomultiplier gain, and offset. These settings were chosen such
that the pixel intensities for the brightest samples were just below saturation,
except that when contours of the cell or contours of the neuronal processes
had to be clearly determined, signals from certain areas (center of the HEK
cell body or soma of the neurons) were saturated in order to obtain clear pe-
rimeter of the cell body or neuronal dendrites. Quantification of fluorescent sig-
nals of immunostained proteins was performed as described (Nam and Chen,
2005). Briefly, images collected using the same confocal settings were thresh-
olded identically by intensity to exclude the diffuse/intracellular pool, and318 Neuron 60, 308–320, October 23, 2008 ª2008 Elsevier Inc.puncta were quantified by counting the number of suprathreshold areas of
sizes between 0.25 and 4 mm2. Results were averaged for at least 15 images
per condition, and the mean and standard error were calculated. Image quan-
tification was performed by experienced investigators who were ‘‘blind’’ to the
experimental conditions.
Synaptoneurosome Preparation
Hippocampi from P15–P21 Sprague-Dawley rats were dissected and gently
homogenized in a solution containing 33% sucrose, 10 mM HEPES, 0.5 mM
EGTA (pH 7.4), and protease inhibitors. Nuclei and other debris were pelleted
at 20003 g for 5min at 4C and the supernatant filtered through three layers of
100 mm pore nylon mesh (Millipore, Bedford, MA) and a 5 mm pore PVDF sy-
ringe filter (Millipore, Bedford, MA). The filtrate was then centrifuged for
10 min at 10,000 3 g at 4C, and the supernatant removed. The synaptoneur-
osome-containing pellet was then resuspended in the appropriate amount of
Minimum Essential Media (Invitrogen, Carlsbad, CA) containing protease
and RNAsin (Amersham, Piscataway, NJ). Equal volumes were then aliquoted
into opaque microfuge tubes. Appropriate samples were pretreated for 30 min
at 37C with 50 mM actinomycin D (Sigma, St Louis, MO), 100 mM cyclohexi-
mide (Sigma, St Louis, MO), or 40 mM anisomycin (Sigma, St Louis, MO). Ap-
propriate concentrations (100 nM, 1 mM, or 10 mM) of retinoic acid (Sigma, St
Louis, MO) or AM580 was added to the samples, which were incubated for
10 min at 37C, and immediately frozen in dry ice afterward.
In Situ Hybridization
Fourteen DIV hippocampal neurons were fixed with 4% paraformaldehyde,
permeabilized with 0.5% Triton X-100 for 5 min, and incubated in DEPC
PBS containing 0.1% active DEPC for 15 min. Cells were then prehybridized
with Rapid-Hyb buffer (Amersham Biosciences, Piscataway, NJ) in 50% form-
amide containing 0.1% Blocking Reagent (Roche, Indianapolis, IN) at 54C.
Hybridizations were performed at 54C, and washes at 50C in 13 SSC con-
taining 50% formamide. Cells were coincubated with an HRP-linked DIG anti-
body and rabbit polyclonal MAP2 antibody for 1 hr at room temperature, and
then processed for tyramide signal amplification using a Cy3-TSA kit (Perkin-
Elmer, Wellesley, MA). MAP2 was detected using Cy5-conjugated goat anti-
mouse antibody. Digoxygenin-labeled GluR1 riboprobes were transcribed
from PCR product T3 and T7 RNA polymerase site adapters. The forward
primer used was 50 T3-CAATCACAGGAACATGCGGC 30 and the reverse
primer 50 T7-TCTCTGCGGCTGTATCCAAG 30.
Statistical Analysis
Single-factor ANOVAwas used for statistical analysis. Values are presented as
mean ± SEM in the figures.
SUPPLEMENTAL DATA
The Supplemental Data can be found with this article online at http://www.
neuron.org/supplemental/S0896-6273(08)00707-1.
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